Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$1.49B
+1.8% from 2023
Prescriptions
775K
$1,926.86 per claim
Patients
185K
93,726 prescribers
Total spending, 2024
$1.49B
$8,061.31 per patient
Medicare prescription drug plans paid $1.49B for Creon in 2024, for 774,822 prescriptions and refills to 185,196 patients (up 1.8% from 2023). The average cost per claim was $1,926.86.
California had the highest Medicare cost for Creon in 2024: $193.6M for 126,647 claims, followed by New York ($171.9M).
Chang S Lee, internal medicine in Flushing, NY, had the highest Medicare cost for Creon in 2024: 1,796 claims costing $1.8M.
Creon is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Chang S Lee Flushing, NY | Internal Medicine | 1,796 | 231 | $1.8M |
| Yuriy Pertsovsky Brooklyn, NY | Gastroenterology | 756 | 151 | $1.6M |
| Jung L Lee Flushing, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 86,900 | 809,419 | 173,827 | $1.31B |
| 2023 | 92,015 | 839,351 | 185,170 | $1.47B |
| 2024 | 93,726 | 774,822 | 185,196 | $1.49B |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| General Surgery |
| 1,627 |
| 295 |
| $1.5M |
| Christopher D Bui Santa Ana, CA | Internal Medicine | 1,112 | 221 | $1.5M |
| Jerry Sullivan Tifton, GA | Physician Assistant | 360 | 149 | $1.5M |
| Chun T Wong New York, NY | Gastroenterology | 525 | 125 | $1.4M |
| Israel Crespo Tampa, FL | Gastroenterology | 238 | 83 | $1.4M |
| Jaesoo Pak Cerritos, CA | Internal Medicine | 748 | 107 | $1.4M |
| Joseph Pilewski Pittsburgh, PA | Pulmonary Disease | 195 | 43 | $1.4M |
| Joo Y Jang Leonia, NJ | Nurse Practitioner | 696 | 153 | $1.4M |
| Soo W Kang Buena Park, CA | Internal Medicine | 1,020 | 208 | $1.3M |
| Mark M Song Los Angeles, CA | Internal Medicine | 868 | 188 | $1.3M |
| Hea-Shin Kang Flushing, NY | Internal Medicine | 1,046 | 150 | $1.3M |
| Weining W Liang Flushing, NY | Internal Medicine | 595 | 123 | $1.3M |
| Li Q Zhang New York, NY | Physician Assistant | 555 | 141 | $1.2M |
| Sang H Baik Los Angeles, CA | Internal Medicine | 1,124 | 272 | $1.0M |
| Juli Kang Leonia, NJ | Nurse Practitioner | 534 | 130 | $1.0M |
| Sonwoo Lee Los Angeles, CA | Internal Medicine | 883 | 251 | $1.0M |
| Jae Y Yoo Los Angeles, CA | Internal Medicine | 950 | 201 | $1.0M |
| Robin R House London, KY | Nurse Practitioner | 207 | 84 | $969K |
| Daniel B Rosenbluth Saint Louis, MO | Pulmonary Disease | 191 | 21 | $959K |
| Shawn S Kim Duluth, GA | Internal Medicine | 595 | 143 | $956K |
| Vlad Nusinovich West Hollywood, CA | Internal Medicine | 999 | 131 | $921K |
| Doeyoung Kim Los Angeles, CA | Internal Medicine | 783 | 158 | $898K |
| Hong S Kim Garden Grove, CA | Internal Medicine | 746 | 171 | $897K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Abbvie US LLC ABBV | 775,061 | $1.49B |